Accendra Health, Inc. (ACH) Cash Flow Statement

As reported in quarterly financial statements, OMI's operating cash flow frequently diverges from net income, evidenced by a volatile OCF/NI ratio that reached -24.50 in 2023Q3, suggesting that accounting losses are not being fully reconciled by cash-generative operational activities across the recent ten-quarter period.

Based on the provided cash flow data, OMI's free cash flow trajectory remains highly erratic, with a significant negative outflow of $230.3 million in 2025Q3, highlighting a structural inability to maintain consistent positive cash generation amidst ongoing operational and strategic restructuring efforts across the business.

According to recent cash flow filings, OMI experiences extreme working capital fluctuations, such as the $139.2 million inflow in 2025Q4 followed by significant outflows in prior periods, which suggests that the company's cash position is highly sensitive to the timing of hospital payments and inventory management.

As indicated by the quarterly data, OMI's capital expenditures remain elevated relative to revenue, with CapEx/Rev ratios peaking at 10.0% in 2025Q2, suggesting that the company is forced to reinvest heavily in its infrastructure despite the ongoing net losses and negative cash flow trends.

Based on the ten-quarter aggregate figures, OMI exhibits a widening gap between cumulative net losses and operating cash flow, which suggests that the company's reported profitability is consistently failing to manifest as tangible cash, raising significant questions about the long-term sustainability of the current business model.